alexa Fisseha Tesfaye |
ISSN: 2329-6607

Cardiovascular Pharmacology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Fisseha Tesfaye

Department of cardiology
Janssen Research and Development
USA
Biography

He is currently working in department of cardiology at Janssen Research and Development, USA. He has many publications in different journals. The main area of research is Cardiomyopathy; Epidemiology of ageing, ventricular arrhythmias, echocardiography, Quality assurance in heart failure.

Research Interest

ventricular arrhythmias, echocardiography, Quality assurance in heart failure

Publications

Effects of JNJ-54452840, an Anti-β1 Receptor Antibody Cyclopeptide in Heart Failure Patients: A Randomized, Double-blind, Parallel-group, Phase-2 Pilot Study

Stefan Störk, Alexei N Plotnikov, Gary Peters, Brian E Davies, Ivo Nnane, David Rivas, Fisseha Tesfaye, Stefan Kääb, Axel Bauer, Andreas Luchner, Martin Ungerer, Roland Jahns, Martin Lohse, and Georg Ertl

Research Article: Cardiovasc Pharm Open Access 2016, 5: 190

DOI: 10.4172/2329-6607.1000190

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords